$150 Million is the total value of Meditor Group Ltd's 4 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EXEL | Sell | EXELIXIS INC | $106,879 | -33.5% | 6,816,300 | -11.7% | 71.10% | -10.5% |
| ESPR | ESPERION THERAPEUTICS INC | $29,941 | +5.3% | 4,468,835 | 0.0% | 19.92% | +41.7% | |
| INDA | ISHARES MSCI INDIA ETF | $6,981 | +3.6% | 171,200 | 0.0% | 4.64% | +39.3% | |
| EPI | WISDOMTREE INDIA EARNINGS FUND | $6,529 | +3.0% | 213,800 | 0.0% | 4.34% | +38.5% |
Signatures
The EDGAR filing(s) were signed by:
- Brian Desmond — Director, Meditor Group Limited
- Meditor Group Ltd holdings (13F-HR)
- Meditor Group Ltd significant holdings (13D/G)
- Meditor Group Ltd ownership history
- Meditor Group Ltd portfolio value
- Meditor Group Ltd filings
- Similar filers BETA
Compare quarterly holdings
Export Meditor Group Ltd's holdings